EP08.02-01 Parameters of FDG PET/CT Predicting Pathological Response to Neoadjuvant Immunotherapy in Stage II/III Non-small Cell Lung Cancer Patients

E. S. Lee,J. Choi, J. H. Lee, K. H. Jo, J. S. Eo, H. K. Kim,H. S. Yong, S. Y. Lee

Journal of Thoracic Oncology（2023）

Cited 0|Views5

Key words

neoadjuvant immunotherapy,FDG PET,stage II/III non-small cell lung cancer

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined